# Ship2B

> Ship2B is a VC fund in Barcelona backing Health Care and Medical Device. See 55 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 55
- Last investment: Nov 2025
- Lead investor: 56%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ship2b
- X (Twitter): http://twitter.com/ship2B
- Website: http://www.ship2b.org/
- Facebook: http://www.facebook.com/ship2b

Ship2B is a VC fund in Barcelona focused on Health Care and Medical Device. Ship2B promotes economic and social enterprises profitability that manages an impact investment vehicle. Ship2B foundation is boosted by big business leaders with the intention of promoting economic and social enterprises profitability, also managing an impact investment vehicle.

## Contacts

5 contacts available for Ship2B. Shizune tracks 2 team members at Ship2B. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/b-come-ship2b?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 19 | 35% |
| Medical Device | 6 | 11% |
| Internet | 5 | 9% |
| Software | 5 | 9% |
| Medical | 4 | 7% |

79 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 18 | 33% |
| Pre-Seed | 14 | 25% |
| Funding Round | 9 | 16% |
| Series A | 5 | 9% |
| Series B | 2 | 4% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Spain | 40 | 73% |
| Ecuador | 1 | 2% |
| Germany | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andreu Gasparin | Director of communication | 0 | https://shizune.co/investors/profile/andreu-gasparin |
| Javier de la Ossa | Acceleration director | 0 | https://shizune.co/investors/profile/javier-de-la-ossa |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Qida | Qida is a home care company that offers expert, personalized, and humane in-home care for elderly or dependent people. This procedure is carried out in accordance with the Individualized Work Plan (PTI), a comprehensive plan that incorporates the major international assessment scales in the health and social fields. Qida is a social impact entitythat selects the best caregiver and also accompanies the person cared for and their family throughout the process through the figure of the Social Reference. | $42.5M | Series B | Nov 04, 2025 |  |
| Dental Residency | Dental Residency is a health services company, whose objective is to improve the quality of life of the elderly through optimal oral health. |  |  | Jul 27, 2023 |  |
| ADmit Therapeutics | ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer. | $6.1M | Venture - Series Unknown | Jul 19, 2023 |  |
| ENKITEK | ENKITEK focuses on creating a set of technological products for the indoor farming industry, in order to make the it more productive and effective. ENKITEK reaches that through the automation of labor processes together with a insightful monitoring of the crops. The technology the company uses are mainly Robotics, Artificial Intelligence and IoT. |  | Pre-Seed | Mar 20, 2023 |  |
| YSOTOPE THERANOSTICS | YSOTOPE uses specific ligands to design co-diagnostic radiotracers to monitor CAR-T cells inside the patient’s body. YSOTOPE is a Spanish company founded in 2022 by a team with experience in deeptech entrepreneurship and radiochemistry. The loss of CAR-T in blood is a problem for oncologists making them more difficult to personalize the treatment.Molecular imaging is a non-invasive solution for providing information about CAR-T therapy to oncologists. |  | Pre-Seed | Mar 20, 2023 |  |
| Novafarma | Novafarma seeks the effectiveness of therapies, minimizing avoidable problems related to treatments, and activating medication review (RM) and drug use (RUM) through our clinical telepharmacy platform. The company's purpose is to improve the quality of life related to the health of patients through our proven methodologies, and through thecompany's provided digital services. |  | Pre-Seed | Mar 20, 2023 |  |
| Geforest | Geforest is a company specialized in 3D scanning or Lidar (Light Detection abd Ranging), digitization and measurement services. The company carries out precise and detailed 3D laser scans of all types of spaces, buildings and infrastructures for the execution of engineering projects, architecture, industrial construction, forest management,heritage conservation, etc. Geforest's services are based on 3D laser technology, which after scanning, it allows the company to obtain a large georeferenced cloud of points. |  | Pre-Seed | Mar 20, 2023 |  |
| Hydros Power | Hydros Power was created with the mission of contributing to the energy revolution needed to reduce the emission of greenhouse gases. Hydros Power was established to develop renewable hydrogen generating stations at different scales. In this way, with the generating station, hydrogen could be produced, compressed, stored and supplied at anylocation. All that would be needed would be water and electricity. In this way, distribution and transportation costs would be zero. |  | Pre-Seed | Mar 20, 2023 |  |
| Point Pressure | Point Pressure is developing a medical device to help patients with chronic diseases or conditions experiencing spasticity through a non-invasive physical treatment. The main aim of the instrument is to treat spasticity symptoms resulting in a wider motion of the affected limbs. |  | Pre-Seed | Mar 20, 2023 |  |
| MedBrain | MedBrain is a diagnostic support system for healthcare professionals working in resource-scarce settings. MedBrain guides physicians, nurses, and community health workers through every step of the diagnostic process and helps them reach accurate diagnoses with primary care resources. |  | Pre-Seed | Mar 20, 2023 |  |

10 of 55 investments shown.

## Co-investors
- [BStartup - Banc Sabadell](https://shizune.co/investors/profile/bstartup-llc) — VC Fund, 4 deals together
- [Equity4Good](https://shizune.co/investors/profile/equity4good) — VC Fund, 4 deals together
- [Sabadell Venture Capital](https://shizune.co/investors/profile/sabadell-venture-capital) — VC Fund, 4 deals together
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund, 3 deals together
- [Capital Cell](https://shizune.co/investors/profile/capital-cell) — VC Fund, 3 deals together
- [INELCOM Ingeniería Electrónica Comercial](https://shizune.co/investors/profile/inelcom-ingenier%C3%ADa-electr%C3%B3nica-comercial) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ship2B invest in?

Ship2B invests primarily in Health Care, Medical Device and Internet startups, most often at Seed and Pre-Seed stage. Most of the 55 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ship2B?

Public channels for Ship2B include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ship2B?

The team at Ship2B includes Andreu Gasparin (Director of communication) and Javier de la Ossa (Acceleration director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co